Innovator IBD Breakout Opportunities ETF (NYSEARCA:BOUT) Short Interest Down 43.8% in July

Innovator IBD Breakout Opportunities ETF (NYSEARCA:BOUT) was the recipient of a significant drop in short interest during the month of July. As of July 15th, there was short interest totaling 456 shares, a drop of 43.8% from the June 30th total of 812 shares. Currently, 0.1% of the shares of the company are short sold. Based on an average trading volume of 3,103 shares, the short-interest ratio is presently 0.1 days.

Hedge Funds Weigh In On Innovator IBD Breakout Opportunities ETF

Several institutional investors and hedge funds have recently added to or reduced their stakes in the business. Osaic Holdings Inc. raised its position in Innovator IBD Breakout Opportunities ETF by 39.7% during the 2nd quarter. Osaic Holdings Inc. now owns 2,102 shares of the company’s stock worth $77,000 after purchasing an additional 597 shares during the last quarter. Comprehensive Wealth Management LLC boosted its holdings in shares of Innovator IBD Breakout Opportunities ETF by 122.0% during the 4th quarter. Comprehensive Wealth Management LLC now owns 23,403 shares of the company’s stock worth $850,000 after buying an additional 12,859 shares in the last quarter. Finally, Susquehanna International Group LLP increased its stake in Innovator IBD Breakout Opportunities ETF by 42.6% in the third quarter. Susquehanna International Group LLP now owns 26,176 shares of the company’s stock valued at $1,020,000 after purchasing an additional 7,817 shares in the last quarter.

Innovator IBD Breakout Opportunities ETF Stock Performance

Shares of BOUT stock traded down $0.55 during trading on Wednesday, hitting $46.21. The company had a trading volume of 377 shares, compared to its average volume of 4,056. The stock’s 50-day moving average price is $47.01 and its 200 day moving average price is $43.12. The firm has a market capitalization of $16.17 million, a P/E ratio of 28.69 and a beta of 1.03. Innovator IBD Breakout Opportunities ETF has a one year low of $35.05 and a one year high of $49.41.

About Innovator IBD Breakout Opportunities ETF

The Innovator IBD Breakout Opportunities ETF (BOUT) is an exchange-traded fund that is based on the IBD Breakout Stocks Total Return index. The fund tracks an index of US-listed stocks that are likely to breakout, as determined by technical analysis. Holdings are weighted by a mix of fundamental and technical factors BOUT was launched on Sep 13, 2018 and is managed by Innovator.